Malignant Hyperthermia experts will discuss Ryanodex® and other topics at a planned meeting this September 20 and 21 in Chicago, Illinois. At the meeting MH experts will talk on how the administration of Ryanodex® might affect MHAUS’ Emergency Therapy for Malignant Hyperthermia now being used by ambulatory surgery centers, hospitals, and office based surgery. In addition, there will also be discussions about: heat and exercise in people who are susceptible to MH, anesthesia workstation preparation, and obtaining blood gasses during an MH event.

Attending the meeting are Professional Advisory Council members and MH Hotline Consultants of Malignant Hyperthermia Association of the United States (MHAUS).

Watch the MHAUS website for more information about Ryanodex®